Proprietary OEM Parts

The National Institutes of Health, under the Department of Health and Human Services, is pursuing a sole-source, firm-fixed-price procurement for proprietary original equipment manufacturer parts and maintenance services for an Orbitrap Ascend mass spectrometer at its Bethesda, Maryland facility. This acquisition is justified under FAR 6.302-1 as only Thermo Fisher Scientific, through its subsidiary Thermo Electron North America LLC, possesses the exclusive proprietary technology, certified diagnostics, factory-trained technicians, and validated software protocols required to maintain instrument performance, data integrity, and operational continuity for critical NIH proteomics research. The contract includes a base year commencing June 5, 2026, and four option years extending through June 4, 2031, with performance taking place exclusively at the NINDS Proteomics Core Facility in Bethesda, MD. No competitive evaluation process is being conducted, and no formal evaluation factors, pricing details, or contract value estimates are provided, as the award is non-competitive by design. Submission of capability statements from small businesses is permitted for informational purposes only, but the contract will be awarded without competition. Proposals must be submitted electronically via email to [email hidden] by April 30, 2026, at 12:00 p.m. EST, and no formal binding contract clauses, packaging requirements, inspection criteria beyond OEM specifications, or payment administration details are included in the available documentation. The sole responsible source designation and reliance on proprietary OEM procedures mean all service deliverables must comply strictly with Thermo Fisher’s certified protocols to ensure sustained mass accuracy, resolution, and sensitivity of the instrument.